In our series of vlogs, Professor Turnbull describes what personalised medicine means to her and her research. Professor Clare Turnbull is a Professor of Translational Cancer Genetics at the ICR and a NHS Consultant in Clinical Cancer Genetics at The Royal Marsden NHS Foundation Trust. Professor Turnbull also works as a Consultant in Public Health Medicine for Public Health England.
In this week’s vlog, Dr Katherine Wood interviews Dr Ali Kay, a research genetic counsellor and rare disease parent. Ali discusses the PREGCARE project and personalised reproductive risk counselling, as well as the importance of patient advocacy groups in the future of personalised medicine.
In our series of vlogs, Professor Leedham discusses precision medicine in cancer and how understanding tumour microenvironments is allowing development of personalised cancer therapeutics such as immunotherapy.
In this week’s vlog, Dr Katherine Wood interviews Ewan Birney, Deputy Director General and Joint Director of EMBL-EBI. Ewan talks about his scientific journey from a young scientist working on the Human Genome Project through the development of The ENCODE Project, to now.
In this week’s vlog, Dr Katherine Wood talks to Arzoo Ahmed from GenomicsEngland about the Newborn Genomes Programme (https://www.genomicsengland.co.uk/initiatives/newborns). Listen in to learn more about the programme, what it aims to achieve, how it will be delivered, and the practical, societal and ethical challenges associated with such an initiative.
In this week’s vlog Sarah Wynn, CEO of Unique (https://rarechromo.org/) talks to Dr Katherine Wood about the amazing work Unique does – supporting families affected by rare chromosome and gene disorders, working with healthcare professionals, and collaborating with researchers – and the importance of personalised medicine to the charity and those it supports.
In today’s vlog, Dr Katherine Wood talks to Professor Anne Goriely about the PREGCARE study and personalised medicine in reproductive biology. They discuss using NGS to provide personalised recurrence risk to couples, pre-conception, who have already had a child affected by a de novo mutation.
Today, Dr Katherine Wood talks to Dr Sofia Douzgou about her work as a Senior Consultant in Medical Genetics, how we can optimise care for patients with rare disease by bridging the gap between lab-based genomic findings and clinical care, and the role of telemedicine in personalised medicine during and post-pandemic.
In today’s vlog, Dr Katherine Wood talks to Edoardo Ostinelli, Senior Researcher, Precision Psychiatry Lab (OxPPL) based at the University of Oxford, about precision medicine in psychiatry. In particular, Edoardo discusses the PETRUSHKA study developed by the OxPPL team, a Randomised Controlled Trial aiming to personalise pharmacological treatment for adults with major depressive disorder in the NHS.
Today, Dr Katherine Wood talks to Professor Dame Kay Davies about her lifetime of research and the prospects of gene therapy and personalised medicine for Duchenne muscular dystrophy, the ethical implications of her research, and advice to early career women in science.